Search research articles
Contact Us
Filters
Showing results (21-30 of 254) with videos related to
Page
of 26
Sort By:
Vaccine
|
April 30, 2013
Vaccine review: "Staphyloccocus aureus vaccines: problems and prospects"
Kathrin U Jansen, Douglas Q Girgenti, Ingrid L Scully, et al.
Journal of Immunological Methods
|
February 26, 1993
A multiparameter flow cytometric method to study surface molecules involved in interactions between subpopulations of cells
J P Aubry, J G Shields, K U Jansen, et al.
Interdisciplinary Topics in Gerontology and Geriatrics
|
April 20, 2020
Vaccination against Nosocomial Infections in Elderly Adults
Annaliesa S Anderson, Ingrid L Scully, Michael W Pride, et al.
Frontiers in Immunology
|
April 10, 2014
Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine
Ingrid L Scully, Paul A Liberator, Kathrin U Jansen, et al.
Human Vaccines & Immunotherapeutics
|
December 9, 2014
Adult vaccination
Kena A Swanson, H Josef Schmitt, Kathrin U Jansen, et al.
Environmental Chemistry Letters
|
October 4, 2021
The impact of human vaccines on bacterial antimicrobial resistance. A review
Kathrin U Jansen, William C Gruber, Raphael Simon, et al.
Nature
|
August 6, 1992
CD21 is a ligand for CD23 and regulates IgE production
J P Aubry, S Pochon, P Graber, et al.
Current Opinion in Microbiology
|
September 8, 2015
Anti-infective vaccination in the 21st century-new horizons for personal and public health
Ingrid L Scully, Kena Swanson, Luke Green, et al.
Vaccine
|
June 22, 2011
The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A
David Cooper, Xinhong Yu, Mohinder Sidhu, et al.
Mbio
|
March 10, 2016
Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection
Annaliesa S Anderson, Ingrid L Scully, Ed T Buurman, et al.
Page
of 26
Search research articles
Search
Showing results (21-30 of 254) with videos related to
Sort By:
Page
of 26
Vaccine
|
April 30, 2013
Vaccine review: "Staphyloccocus aureus vaccines: problems and prospects"
Kathrin U Jansen, Douglas Q Girgenti, Ingrid L Scully, et al.
Journal of Immunological Methods
|
February 26, 1993
A multiparameter flow cytometric method to study surface molecules involved in interactions between subpopulations of cells
J P Aubry, J G Shields, K U Jansen, et al.
Interdisciplinary Topics in Gerontology and Geriatrics
|
April 20, 2020
Vaccination against Nosocomial Infections in Elderly Adults
Annaliesa S Anderson, Ingrid L Scully, Michael W Pride, et al.
Frontiers in Immunology
|
April 10, 2014
Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine
Ingrid L Scully, Paul A Liberator, Kathrin U Jansen, et al.
Human Vaccines & Immunotherapeutics
|
December 9, 2014
Adult vaccination
Kena A Swanson, H Josef Schmitt, Kathrin U Jansen, et al.
Environmental Chemistry Letters
|
October 4, 2021
The impact of human vaccines on bacterial antimicrobial resistance. A review
Kathrin U Jansen, William C Gruber, Raphael Simon, et al.
Nature
|
August 6, 1992
CD21 is a ligand for CD23 and regulates IgE production
J P Aubry, S Pochon, P Graber, et al.
Current Opinion in Microbiology
|
September 8, 2015
Anti-infective vaccination in the 21st century-new horizons for personal and public health
Ingrid L Scully, Kena Swanson, Luke Green, et al.
Vaccine
|
June 22, 2011
The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A
David Cooper, Xinhong Yu, Mohinder Sidhu, et al.
Mbio
|
March 10, 2016
Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection
Annaliesa S Anderson, Ingrid L Scully, Ed T Buurman, et al.
Page
of 26